Evidence map›Paper›PMID 30353292›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Whole Cell MALDI Fingerprinting Is a Robust Tool for Differential Profiling of Two-Component Mammalian Cell Mixtures.

Valentina Z Petukhova, Alexandria N Young, Jian Wang, Mingxun Wang, Andras Ladanyi, Rajul Kothari, Joanna E Burdette, Laura M Sanchez

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Valentina Z PetukhovaDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S Wood St., MC 781, Room 539, Chicago, IL, 60612, USA.
Alexandria N YoungDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S Wood St., MC 781, Room 539, Chicago, IL, 60612, USA.
Jian WangOmeta Labs, 3210 Merryfield Row, San Diego, CA, 92121, USA.
Mingxun WangOmeta Labs, 3210 Merryfield Row, San Diego, CA, 92121, USA.
Andras LadanyiDepartment of Obstetrics & Gynecology, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL, 60612, USA.
Rajul KothariDepartment of Obstetrics & Gynecology-Division of Gynecologic Oncology, University of Illinois at Chicago, 820 S Wood St., Chicago, IL, 60612, USA.
Joanna E BurdetteDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S Wood St., MC 781, Room 539, Chicago, IL, 60612, USA.
Laura M SanchezDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S Wood St., MC 781, Room 539, Chicago, IL, 60612, USA. sanchelm@uic.edu.ORCID http://orcid.org/0000-0001-9223-7977
University of Illinois Chicago · USRush University Medical Center · US

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
UIC Program for Interdisciplinary Careers in Women's Health ResearchK12HD055892 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GELLER, STACIE E. · 2007 to 2016
$4.9M
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive PlatformUG3ES029073 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2017 to 2018
$3.0M
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeuticsF30CA217079 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YOUNG, ALEXANDRIA · 2017 to 2020
$184k
NCATS NIH HHS UL1 TR002003NCATS NIH HHS UL1TR002003NCI NIH HHS F30 CA217079NICHD NIH HHS K12 HD055892NIEHS NIH HHS UG3 ES029073Office of Research on Women's Health K12HD055892
6 · The paper itself

Abstract

MALDI fingerprinting was first described two decades ago as a technique to identify microbial cell lines. Microbial fingerprinting has since evolved into an automated platform for microorganism identification and classification, which is now routinely used in clinical and environmental sectors. The extension of fingerprinting to mammalian cells has yet to progress partly due to compartmentalization of eukaryotic cells and overall higher cellular complexity. A number of publications on mammalian whole cell fingerprinting suggest that the method could be useful for classification of different cell types, cell states, and monitoring cell differentiation. We report the optimization of MALDI fingerprinting workflow parameters for mammalian cells and its application for differential profiling of mammalian cell lines and two-component cell line mixtures. Murine fallopian tube cells and high-grade ovarian carcinoma cell lines and their mixtures are used as model mammalian cell lines. Two-component cell mixtures serve to determine the method's feasibility for complex biological samples as the ability to detect cancer cells in a mixed cell population. The level of detection of cancer cells in the two-component mixture by principle component analysis (PCA) starts to deteriorate at 5% but with application of a different statistical approach, Wilcoxon rank sum test, the level of detection was determined to be 1%. The ability to differentiate heterogeneous cell mixtures will help further extend whole cell MALDI fingerprinting to complex biological systems. Graphical Abstract.

Indexed as

AnimalsCell Line, TumorCells, CulturedCytodiagnosisFallopian TubesFemaleHumansMiceReproducibility of ResultsSolventsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationWorkflowSolventsMammalian cell linesTwo-component cell line populationsWhole cell MALDI fingerprinting

Identifiers

PMID30353292
PMCPMC6347503
OpenAlexW2897059652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.